Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study. Voprosy onkologii, v. 72, n. 4, p. 2630, 15 Sep.2026.